Extrakorporale Membranoxygenierung bei Lungenversagen des reifen Neugeborenen

• Literatur

• 1 Clark RH. The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. J Perinatol 2005; 25: 251-257
• 2 Dellinger RP, Levy MM, Carlet JM et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; 36: 296-327
• 3 Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308
• 4 Peter JV, John P, Graham PL et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: Meta-analysis. BMJ 2008; 336: 1006-1009
• 5 Hallman M, Merritt TA, Jarvenpaa AL et al. Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial. J Pediatr 1985; 106: 963-969
• 6 Lotze A, Mitchell BR, Bulas DI et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 1998; 132: 40-47
• 7 Herting E, Gefeller O, Land M et al. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group. Pediatrics 2000; 106: 957-964
• 8 Duffett M, Choong K, Ng V et al. Surfactant therapy for acute respiratory failure in children: A systematic review and meta-analysis. Crit Care 2007; 11: R66
• 9 The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follw-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 2000; 136: 611-617
• 10 Adhikari NK, Burns KE, Friedrich JO et al. Effect of nitric oxide on oxygenation and mortality in acute lung injury: Systematic review and meta-analysis. BMJ 2007; 334: 779
• 11 Petrucci N, Iacovelli W. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2007; 18 CD003844
• 12 Sud S, Sud M, Friedrich JO et al. High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): systematic review and meta-analysis. BMJ 2010; 340: C2327
• 13 Schaible T, Hermle D, Loersch F et al. A 20-year experience on neonatal extracorporeal membrane oxygenation in a referral center. Intensive Care Med 2010; 36: 1229-1234
• 14 Keller RL, Tacy TA, Hendricks-Munoz K et al. Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am J Respir CritCare Med 2010; 182: 555e61
• 15 Kachel W, Schaible T. ECMO beim Neugeborenen. In: Rieger C, Hardt HVD, Sennhauser SH, et al. (Hrsg.) Pädiatrische Pneumologie. 2. . Aufl. Berlin, Heidelberg, New York: Springer; 2004
• 16 Mc Nally H, Bennett CC, Elbourne D. UK Collaborative ECMO Trial Group et al. United Kingdom collaborative randomized trial of neonatal extracorporeal membrane oxygenation: follw-up to age 7 years. Pediatrics 2006; 117: e845-854
• 17 Extracorporal Life Support Organization registry. ECLS registry report. AnnArbor, MI: ELSO; 2013
• 18 Hout LVD, Schaible T, Cohen-Overbeek TE et al. Actual outcome in infants with congenital diaphragmatic hernia: the role of a standardized postnatal treatment protocol. Fetal Diagn Ther 2011; 29: 55-63